Distribution of tau proteins in the normal human central and peripheral nervous systemJQ Trojanowski, T Schuck, ML Schmidt and VM Lee Department of Pathology and Laboratory Medicine (Neuropathology), University of Pennsylvania School of Medicine, Philadelphia 19104-6079. In human brain, antibodies to tau proteins primarily label abnormal rather than normal structures. This might reflect altered immunoreactivity owing to post-mortem proteolysis, disease, or species differences. We addressed this issue by comparing the distribution of tau in bovine and human post-mortem nervous system tissues and in human neural cell lines, using new monoclonal antibodies (MAb) specific for phosphate-independent epitopes in bovine and human tau. In neocortex, hippocampus, and cerebellum, immunoreactive tau was widely expressed but segregated into the axon-neuropil domain of neurons. In spinal cord and peripheral nervous system, tau immunoreactivity was similarly segregated but less abundant. No immunoreactive tau was detected with our MAb in glial cells or in human neural cell lines that express neurofilament or glial filament proteins. Post-mortem delays in tissue denaturation of less than 24 hr did not affect the distribution of tau, but the method used to denature tissues did, i.e., microwave treatment preserved tau immunoreactivity more effectively than chemical fixatives such as Bouin's solution, and formalin-fixed tissue samples reacted poorly with our anti-tau MAb. We conclude that the distribution of tau proteins in human nervous system is similar to that described in perfusion-fixed experimental animals, and that visualization of normal immunoreactive tau in human tissues is critically dependent on the procedures used to denature post-mortem tissue samples. Furthermore, microenvironmental factors in different neuroanatomical sites may affect the regional expression of tau.
Volume 37,
Issue 2,
pp. 209-215,
02/01/1989
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
D. W. Shineman, B. Zhang, S. N. Leight, D. Pratico, and V. M.-Y. Lee Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice J. Neurosci., April 30, 2008; 28(18): 4785 - 4794. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Norris, K. Uryu, S. Leight, B. I. Giasson, J. Q. Trojanowski, and V. M.-Y. Lee Pesticide Exposure Exacerbates {alpha}-Synucleinopathy in an A53T Transgenic Mouse Model Am. J. Pathol., February 1, 2007; 170(2): 658 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Uryu, C. Richter-Landsberg, W. Welch, E. Sun, O. Goldbaum, E. H. Norris, C.-T. Pham, I. Yazawa, K. Hilburger, M. Micsenyi, et al. Convergence of Heat Shock Protein 90 with Ubiquitin in Filamentous {alpha}-Synuclein Inclusions of {alpha}-Synucleinopathies Am. J. Pathol., March 1, 2006; 168(3): 947 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Lee, L. Z. Leng, B. Zhang, L. Kwong, J. Q. Trojanowski, T. Abel, and V. M.-Y. Lee Targeting Amyloid-beta Peptide (Abeta) Oligomers by Passive Immunization with a Conformation-selective Monoclonal Antibody Improves Learning and Memory in Abeta Precursor Protein (APP) Transgenic Mice J. Biol. Chem., February 17, 2006; 281(7): 4292 - 4299. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Lee, B. Zhang, K. Liu, E. A. Greenbaum, R. W. Doms, J. Q. Trojanowski, and V. M.-Y. Lee BACE overexpression alters the subcellular processing of APP and inhibits A{beta} deposition in vivo J. Cell Biol., January 17, 2005; 168(2): 291 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vogelsberg-Ragaglia, J. Bruce, C. Richter-Landsberg, B. Zhang, M. Hong, J. Q. Trojanowski, and V. M.-Y. Lee Distinct FTDP-17 Missense Mutations in Tau Produce Tau Aggregates and Other Pathological Phenotypes in Transfected CHO Cells Mol. Biol. Cell, December 1, 2000; 11(12): 4093 - 4104. [Abstract] [Full Text] |
||||
![]() |
J. E. Duda, B. I. Giasson, Q. Chen, T. L. Gur, H. I. Hurtig, M. B. Stern, S. M. Gollomp, H. Ischiropoulos, V. M.-Y. Lee, and J. Q. Trojanowski Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies Am. J. Pathol., November 1, 2000; 157(5): 1439 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Murayama, R.-W. Shin, J. Higuchi, S. Shibuya, T. Muramoto, and T. Kitamoto Interaction of Aluminum with PHF{tau} in Alzheimer's Disease Neurofibrillary Degeneration Evidenced by Desferrioxamine-Assisted Chelating Autoclave Method Am. J. Pathol., September 1, 1999; 155(3): 877 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liao, Y. Li, D. L. Brautigan, and G. G. Gundersen Protein Phosphatase 1 Is Targeted to Microtubules by the Microtubule-associated Protein Tau J. Biol. Chem., August 21, 1998; 273(34): 21901 - 21908. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Lee, S. Newman, D. Gard, H Band, and G Panchamoorthy Tau interacts with src-family non-receptor tyrosine kinases J. Cell Sci., January 11, 1998; 111(21): 3167 - 3177. [Abstract] [PDF] |
||||
![]() |
M. Hong, D. C. R. Chen, P. S. Klein, and V. M.-Y. Lee Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3 J. Biol. Chem., October 3, 1997; 272(40): 25326 - 25332. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hong and V. M.-Y. Lee Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons J. Biol. Chem., August 1, 1997; 272(31): 19547 - 19553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Merrick, J. Q. Trojanowski, and V. M.-Y. Lee Selective Destruction of Stable Microtubules and Axons by Inhibitors of Protein Serine/Threonine Phosphatases in Cultured Human Neurons (NT2N Cells) J. Neurosci., August 1, 1997; 17(15): 5726 - 5737. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-h. Tu, K. A. Robinson, F. de Snoo, J. Eyer, A. Peterson, V. M.-Y. Lee, and J. Q. Trojanowski Selective Degeneration of Purkinje Cells with Lewy Body-Like Inclusions in Aged NFHLACZ Transgenic Mice J. Neurosci., February 1, 1997; 17(3): 1064 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kempf, A. Clement, A. Faissner, G. Lee, and R. Brandt Tau Binds to the Distal Axon Early in Development of Polarity in a Microtubule- and Microfilament-Dependent Manner J. Neurosci., September 15, 1996; 16(18): 5583 - 5592. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Mandell and G. A. Banker A Spatial Gradient of Tau Protein Phosphorylation in Nascent Axons J. Neurosci., September 15, 1996; 16(18): 5727 - 5740. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Merrick, D. C. Demoise, and V. M.-Y. Lee Site-specific Dephosphorylation of Tau Protein at Ser[IMAGE]/Thr[IMAGE] in Response to Microtubule Depolymerization in Cultured Human Neurons Involves Protein Phosphatase 2A J. Biol. Chem., March 8, 1996; 271(10): 5589 - 5594. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Seubert, M. Mawal-Dewan, R. Barbour, R. Jakes, M. Goedert, G. V. W. Johnson, J. M. Litersky, D. Schenk, I. Lieberburg, J. Q. Trojanowski, et al. Detection of Phosphorylated Ser[IMAGE] in Fetal Tau, Adult Tau, and Paired Helical Filament Tau J. Biol. Chem., August 11, 1995; 270(32): 18917 - 18922. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Leger, R Brandt, and G Lee Identification of tau protein regions required for process formation in PC12 cells J. Cell Sci., January 12, 1994; 107(12): 3403 - 3412. [Abstract] [PDF] |
||||
![]() |
V. Lee, B. Balin, L Otvos Jr, and J. Trojanowski A68: a major subunit of paired helical filaments and derivatized forms of normal Tau Science, February 8, 1991; 251(4994): 675 - 678. [Abstract] [PDF] |
||||
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |